Stocks

Company news: Dr Reddy’s Laboratories

| Updated on March 20, 2020 Published on March 20, 2020

Dr Reddy’s Laboratories on Friday said it has launched Pyrimethamine tablets, used for treating parasitic disease toxoplasmosis, in the US market. The company’s product is the only generic version of Daraprim tablet which has been approved by the US Food and Drug Administration (USFDA). The company is offering the product at a substantially discounted price to the current brand in the market. As per IQVIA Health, the Daraprim brand had sales of around $10 million for the 12 months ended January 2020. Shares of Dr Reddy’s Laboratories surged 10.50 per cent at ₹2,898.10 on the BSE.

Published on March 20, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.